CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 71 enrolled
Drug / intervention
HQ® Matrix Medical Wound Dressing +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01993030
NCT01993030N/ACompleted
CompareCT.gov

Randomized, Active-controlled, Single-blind, Parallel Two-group Trial of HQ® Matrix Medical Wound Dressing and Sidaiyi® Wound Dressing for the Treatment of Donor Site Wounds

Zhejiang Xingyue Biotechnology Co., Ltd.·interventional·Posted Nov 25, 2013·Updated Jun 19, 2015

In Brief

A clinical study evaluating HQ® Matrix Medical Wound Dressing and Sidaiyi® wound dressing for Donor Site Wound. Completed, enrolled 71 participants across 2 sites.

Detailed Summary

The purpose of the study is to evaluate the safety and effectiveness of HQ® Matrix Medical Wound Dressing for repair of donor site wounds. Half of participants will receive HQ® Matrix Medical Wound Dressing, while the other half will receive Sidaiyi® wound dressing.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDonor Site Wound
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedNov 25, 2013
Enrollment StartAug 1, 2013
Primary CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 12.6 years ago

Interventions

HQ® Matrix Medical Wound Dressingdevice

Sidaiyi® wound dressingdevice